NCT04145518 2025-12-12
MCUP
Endeavor Health
Phase 4 Completed
Clinical Trials
9 trialsNCT05411718 2025-11-13
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT02052908 2021-01-25
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
National Cancer Institute (NCI)
Phase 1 Completed
NCT02500641 2019-06-21
FORWARD
Menarini International Operations Luxembourg SA
Phase 4 Completed
NCT01612975 2018-02-15
The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection
McMaster University
Phase 2 Terminated
NCT01712009 2018-01-30
NOLAN
Amgen
Phase 2 Completed
NCT00602420 2015-11-09
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
University of Rochester
Phase 3 Completed
NCT00383487 2013-01-28
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Stanford University
Phase 2 Terminated